Skip to main content
OpenTrials

Clinical trial condition

Non-Small-Cell Lung Carcinoma

Explore clinical trials studying Non-Small-Cell Lung Carcinoma. Study availability and eligibility vary by location and protocol.

61 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Non-Small-Cell Lung Carcinoma trial results

Recruiting

A Post Approval Commitment Study on Tabrecta® (Capmatinib) in South Korea

NCT05703516

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Bronchial Neoplasms, +13 more
Locations
  • Novartis Investigative Site Daegu, Dalseo gu, South Korea
  • Novartis Investigative Site Suwon, Gyeonggi-do, South Korea
  • Novartis Investigative Site Incheon, Korea, South Korea
  • Novartis Investigative Site Seoul, Korea, South Korea
View Trial Details
Active, not recruiting

A Study of AZD2936 Anti-TIGIT/Anti-PD-1 Bispecific Antibody in Participants With Advanced or Metastatic NSCLC

NCT04995523

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +13 more
Locations
  • Research Site Chicago, Illinois, United States
  • Research Site Rochester, Minnesota, United States
  • Research Site Fairfax, Virginia, United States
  • Research Site Melbourne, Australia
View all 40 locations
View Trial Details
Active, not recruiting

Acupuncture for Enhancing Immunotherapy in Advanced NSCLC：a Pilot Study

NCT06461338

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • The First Affiliated Hospital of Guangzhou University of Chinese Medicine. Guangzhou, Guangdong, China
  • Guangdong Provincial Hospital of Chinese Medicine Guangzhou, Guangdong, China
  • Jiangsu Provincial Hospital of Chinese Medicine Nanjing, Jiangsu, China
View Trial Details
Completed

Coformulation of Pembrolizumab/Vibostolimab (MK-7684A) Versus Pembrolizumab (MK-3475) Monotherapy for Programmed Cell Death 1 Ligand 1 (PD-L1) Positive Metastatic Non-Small Cell Lung Cancer (MK-7684A-003, KEYVIBE-003)

NCT04738487

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Boca Raton Regional Hospital ( Site 0004) Boca Raton, Florida, United States
  • Illinois Cancer Care ( Site 0026) Peoria, Illinois, United States
  • Mercy Research - Cancer and Hematology Center ( Site 0032) Springfield, Missouri, United States
  • Mercy Research - David C. Pratt Cancer Center ( Site 0025) St Louis, Missouri, United States
View all 188 locations
View Trial Details
Completed

Study of REGN 2810 Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC)

NCT03088540

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
Locations
  • Clinical Study Site Albury, New South Wales, Australia
  • Clinical Study Site Wollongong, New South Wales, Australia
  • Clinical Study Site Fitzroy, Australia
  • Clinical Study Site Minsk, Belarus
View all 192 locations
View Trial Details

Related conditions